Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

Avila Therapeutics designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Avila Therapeutics operates as a subsidiary of Celgene Corporation.

ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in the commercialization of treatments for unmet medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. It is the developer of a treatment known as Cialis (tadalafil), a product for the treatment of erectile dysfunction through its joint venture with Eli Lilly and Company in North America and Europe. It is also engaged in contract manufacturing services for third parties. It is in a strategic alliance with Solvay Pharmaceuticals, Inc. ICOS Corporation was established in 1989, based in Bothell, Washington. It is currently operated by Eli Lilly and Company.

Cancer Therapeutics CRC Pty Ltd. engages in research and development novel oncology drug and clinical diseases. It focuses in recombinant protein production, structural biology, DMPK, and translational cancer biology. The company was founded in 2007 and is headquartered in Melbourne, Australia.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company's strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.

Celgene CAR LLC, part of Bristol Myers Squibb Co., is an American company that develops therapies for the treatment of cancer and inflammatory diseases.

Enrui Biomedical Technology (Shanghai) Co., Ltd., established on 2011-01-05, Business scope includes research on new drugs and biomedical technology,to develop(remove human stem cells,Development and application of genetic diagnosis and treatment technology),And provide relevant technical advice,Technical Services,transfer of own technology.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Jiangxi Shumate Pharmaceutical Co., Ltd., established on 2013-04-16, Business scope includes health food sales;food research and development,Production,Sales;Chinese herbal medicine,Chinese Herbal Medicine,Chinese patent medicine,Chemical raw materials and their preparations,Antibiotic raw materials and their preparations,biochemical drug,Wholesale of biological products;Wholesale and retail of medical equipment(The operating permit);disinfection products,hygiene products,cosmetic,Daily necessities,Electronic equipment,imaging equipment,Security equipment,Communication equipment,Computers and Peripherals,steel,hardware,building materials(Excluding hazardous chemicals)Sales;Import and export of self-operated and agent commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)**

Beijing Hengyu Vision Biotechnology Co., Ltd., established on 2006-05-24, Business scope includes technology development,technology transfer,technical consulting,Technical Services,Technology Promotion,Technical Training;Technology Import and Export;Import and export;Agent import and export;sell electronics,communication equipment,Equipment,computer,Software and Auxiliary Equipment.(Except for projects without administrative permission)(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

argenx IIP BV, part of argenx SE, is a Belgian company. The firm engages in biotechnology research and development business.